Journal of Infection and Public Health
Volume 3, Issue 2 , Pages 60-66 , 2010

Antimicrobial resistance in clinical isolates of Streptococcus pneumoniae in a tertiary hospital in Kuwait, 1997–2007: Implications for empiric therapy

  • Molly Johny

      Affiliations

    • Clinical Microbiology Unit, Department of Laboratory Medicine, Al-Amiri Hospital, Ministry of Health, Kuwait
    • ,
  • Mohammed Babelly

      Affiliations

    • Clinical Microbiology Unit, Department of Laboratory Medicine, Al-Amiri Hospital, Ministry of Health, Kuwait
    • ,
  • Ina’am Al-Obaid

      Affiliations

    • Clinical Microbiology Unit, Department of Laboratory Medicine, Al-Sabah Hospital, Ministry of Health, Kuwait
    • ,
  • Kaleefa Al-Benwan

      Affiliations

    • Clinical Microbiology Unit, Department of Laboratory Medicine, Al-Amiri Hospital, Ministry of Health, Kuwait
    • ,
  • Edet E. Udo

      Affiliations

    • Department of Microbiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, 13110 Safat, Kuwait
    • Corresponding Author InformationCorresponding author. Tel.: +965 2 4986773; fax: +965 2 5332719.

Received 14 September 2009 ,Revised 2 December 2009 ,Accepted 21 February 2010.

References 

  1. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant S. pneumoniae in the United States. N Engl J Med. 2000;43:17–1924
  2. Goldstein FW. Penicillin-resistant Streptococcus pneumoniae: selection by both beta-lactam and non-beta-lactam antibiotics. J Antimicrob Chemother. 1999;44:141–144
  3. Song J, Jung S, Ko KS, Kim NY, Son JS, Chang H, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004;48:2101–2107
  4. Reinert RR, Reinert S, van der Linden M, Cil MY, Al-Lahham A, Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001–2003. Antimicrob Agents Chemother. 2005;49:2903–2913
  5. Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis. 2005;40:1288–1297
  6. Kaplan SL, Mason EO. Management of infections due to antibiotic resistant Streptococcus pneumoniae. Clin Microbiol Rev. 1998;11:628–644
  7. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 15th Informational Supplement M100-S15. Wayne, PA: CLSI; 2005.
  8. Infectious Diseases Society of America . Penicillin's back. FDA raises breakpoints for S. pneumoniae pneumonia. IDSA News. 2008;18:2–3
  9. Doern GV. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin Infect Dis. 2001;33:S187–S192
  10. Johny M, Narayanan S, Murad MA. Rising incidence of beta-lactam resistance among pneumococci in Kuwait: failure of cefotaxime therapy in pneumococcal meningitis. Med Prin Pract. 1998;7:215–222
  11. Johny M, Anton AY, Murad MA. Relative resistance of Pneumococci to penicillin: detection and prevalence in Kuwait. Med Prin Pract. 1992;3:167–170
  12. Mokaddas EM, Wilson S, Sanyal SC. Prevalence of penicillin-resistant Streptococcus pneumoniae in Kuwait. J Chemother. 2001;13:154–160
  13. Shibl AM, Al-Rasheed AM, El-Bashier AM, Osoba AO. Penicillin-resistant and intermediate Streptococcus pneumoniae in Saudi Arabia. J Chemother. 2000;12:134–137
  14. Wasfy MO, Pimentel G, Adel-Maksoud M, Russel KL, Barrozo CP, Klena JD, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998–2003. J Antimicrob Agents Chemother. 2005;55:958–964
  15. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Marby IR, Musher DM, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med. 2000;160:1399–1408
  16. Dowell SF, Butler JC, Giebink SG, Jacobs MR, Jernigan D, Musher DM, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance—a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1–9
  17. Caballero-Granado FJ, Palomino-Nicas J, Pachon J, Garcia-Curiel A. Cefuroxime efficacy in treatment of bacteremic pneumonia due to penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996;40:1325–1326
  18. Yu VL, Chiou CCC, Feldman C, Ortqvist A, Rello J, Morris AJ, et al. Klugman KP for the International Pneumococcal Study Group. Clin Infect Dis. 2003;37:230–237
  19. Leiberman J. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance. Pediatr Infect Dis J. 2003;22:1143–1151
  20. Klugman KP, Koornof HJ, Friedland IR. Antibiotic resistance in pneumococcal meningitis. Lancet. 1992;340:437–438
  21. Feldman C. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med. 2004;143:269–283
  22. Musher DM, Dowell ME, Shortridge VD, Jorgensen JH, Le Magueres P. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N Engl J Med. 2002;346:630–631
  23. Memish ZA, Arabi YM, Ahmed QA, Shibl AM, Niederman MS The GCC CAP Working Group (GCC-CAPWG). Management and prevention strategies for community-acquired pneumonia in the Gulf Corporation Council. J Chemother. 2007;19(Suppl. 1):33–46

PII: S1876-0341(10)00023-7

doi: 10.1016/j.jiph.2010.02.003

Journal of Infection and Public Health
Volume 3, Issue 2 , Pages 60-66 , 2010

Article Tools

* Image Usage & Resolution